1. Home
  2. CCB vs DCTH Comparison

CCB vs DCTH Comparison

Compare CCB & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coastal Financial Corporation

CCB

Coastal Financial Corporation

N/A

Current Price

$43.26

Market Cap

633.6M

Sector

Finance

ML Signal

N/A

DCTH

Delcath Systems Inc.

N/A

Current Price

$14.07

Market Cap

578.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCB
DCTH
Founded
1997
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
633.6M
578.4M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
CCB
DCTH
Price
$43.26
$14.07
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
★ $51.00
$24.00
AVG Volume (30 Days)
198.0K
★ 264.6K
Earning Date
10-29-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 107.53
EPS
N/A
★ 0.04
Revenue
N/A
N/A
Revenue This Year
$4.17
$24.61
Revenue Next Year
$20.89
$24.27
P/E Ratio
★ N/A
$364.00
Revenue Growth
N/A
N/A
52 Week Low
$35.56
$8.12
52 Week High
$120.05
$17.42

Technical Indicators

Market Signals
Indicator
CCB
DCTH
Relative Strength Index (RSI) 46.32 37.69
Support Level $36.09 $11.43
Resistance Level $50.78 $16.51
Average True Range (ATR) 1.90 0.53
MACD 0.39 -0.01
Stochastic Oscillator 32.15 8.06

Price Performance

Historical Comparison
CCB
DCTH

About CCB Coastal Financial Corporation

Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: